What’s Next For REGENXBIO Stock After A 20% Fall Yesterday?
- Wednesday, October 6, 2021, 7:28
- Market
- Add a comment
REGENXBIO stock declined by 20% yesterday, while it is down 26% in the last ten trading days. In comparison, the broader S&P500 index declined by 1.4% over the same period. REGENXBIO, a clinical-stage biotechnology company focused on gene therapies, saw its stock fall after releasing phase two…
About the Author
admin123 has written 23402 stories on this site.
